WEDNESDAY, April 24, 2024 (HealthDay News) — A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says. That’s because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the risk of heartContinue Reading

THURSDAY, April 1, 2024 (HealthDay News) — In a letter sent to teaching hospitals and medical schools across the country, the U.S. Department of Health and Human Services said Monday that written consent must be obtained from patients before performing sensitive procedures such as pelvis and prostate exams. The agencyContinue Reading

FRIDAY, March 29, 2024 (HealthDay News) — Stem cells derived from a patient’s own fat can safely help improve sensation and movement after a spinal cord injury, a new, small study finds. Patients treated with these stem cells experienced increased sensation from pinpricks and light touches, increased muscle strength andContinue Reading